21 May 2009
Influence of viral infections on allografts function and acute graft rejection (agr) in both donors and recipients
P Jurkowski, A Mikłaszewicz, M Cićkiewicz, P Orszulak, M Fiedor, Z Lewandowski, P FiedorAnn Transplant 2009; 14(1): 74-74 :: ID: 880471
Abstract
Background: Virus infections play a key role and directly influence allograft
function in recipients under chronic immunosuppression. The aim of this study was to evaluate the infl uence of CMV, EBV, HBV and HCV virus infections in both donors and recipients on graft stability.
Material/Methods: The medical histories of 171 kidney and liver allograft recipients were analyzed in search of viral infections. Next, every recipient was matched with their donors. It was evaluated how different viral infections influence the time of acute graft rejection.
Results: There was no significant difference in the time of acute rejection time between HBVAg positive and HBVAg negative recipients (p>0.05). Seven months after transplantation, the number of Anti-HCV positive recipients after AGR was twice as big as the number of Anti-HCV negative patients (p=0.0176). Seven months after transplantation, the number of CMV-IgM positive recipients after AGR was three times as big as the number of CMV-IgM negative patients(p=0.0292). There was found no correlation between EBV infection and acute rejection time.
Conclusions: Our data strongly indicate that both HCV and CMV virus infections worsen allograft stability in transplant recipients and immunosuppression is an independent risk factor.
Keywords: CMV infections, HBV infection, HCV infection, viral infections
In Press
Original article
Preoperative Evidence-Based Practice for Prevention of Early Postoperative Infections in Patients Receiving...Ann Transplant In Press; DOI: 10.12659/AOT.943610
Original article
Prediction of Renal Graft Function 1 Year After Adult Deceased-Donor Kidney Transplantation Using Variables...Ann Transplant In Press; DOI: 10.12659/AOT.944603
Original article
Impact of Donor-Recipient Relationship on Long-Term Outcomes in Living-Related Donor Kidney TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.945065
Case report
Successful Interventional Therapy for Portal Vein Stenosis after Ex Vivo Liver Resection and Autotransplant...Ann Transplant In Press; DOI: 10.12659/AOT.944851
Most Viewed Current Articles
05 Apr 2022 : Original article 12,809
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 9,770
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
12 Jan 2022 : Original article 9,215
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
15 Mar 2022 : Case report 7,014
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860